Skip to main content
https://pbs.twimg.com/media/FbV_4kKXkAQNf87.jpg
Phase 2 RCTs are evaluating TLR 7 & TLR 8 blockade in SLE - BMS has afimetoran and Merck has enpatoran (both blocking TLR7/8) https://t.co/lSvnAkRvxB https://t.co/i7ZORYyKHP
Dr. John Cush
29-08-2022
×